Tag: San Diego

MediFormatica Daily Digest – Wednesday, April 19, 2023 – (18 posts)

Daily Digest

In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.

Continue Reading

MediFormatica Daily Digest – Wednesday, April 19, 2023 – (18 posts)

Daily Digest

In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.

Continue Reading

MediFormatica Daily Digest – Thursday, March 23, 2023 – (40 posts)

Daily Digest

In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.

Continue Reading
MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MedCity News

A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…

Continue Reading